Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Cash from Investing Activities (2018 - 2023)

Avai Bio's Cash from Investing Activities history spans 5 years, with the latest figure at -$149000.0 for Q2 2023.

  • On a quarterly basis, Cash from Investing Activities fell 544.64% to -$149000.0 in Q2 2023 year-over-year; TTM through Mar 2024 was -$149000.0, a 344.64% decrease, with the full-year FY2024 number at -$149000.0, down 344.64% from a year prior.
  • Cash from Investing Activities hit -$149000.0 in Q2 2023 for Avai Bio, down from -$67020.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for AVAI hit a ceiling of $33510.0 in Q2 2022 and a floor of -$149000.0 in Q2 2023.
  • Historically, Cash from Investing Activities has averaged -$61580.4 across 4 years, with a median of -$75000.0 in 2019.
  • Biggest five-year swings in Cash from Investing Activities: crashed 4047.37% in 2019 and later tumbled 544.64% in 2023.
  • Tracing AVAI's Cash from Investing Activities over 4 years: stood at -$75000.0 in 2019, then soared by 130.43% to $22821.0 in 2020, then plummeted by 393.68% to -$67020.0 in 2022, then crashed by 122.32% to -$149000.0 in 2023.
  • Business Quant data shows Cash from Investing Activities for AVAI at -$149000.0 in Q2 2023, -$67020.0 in Q3 2022, and $33510.0 in Q2 2022.